Search research articles
Contact Us
Filters
Showing results (21-30 of 31) with videos related to
Page
of 4
Sort By:
Plos Pathogens
|
August 27, 2021
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART
Maria Pino, Susan Pereira Ribeiro, Amélie Pagliuzza, et al.
Journal of the International AIDS Society
|
July 11, 2018
Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC<sup>+</sup> CD4<sup>+</sup> cell levels: a surrogate marker candidate of HIV-induced intestinal damage
Mickaël J Ploquin, Armanda Casrouge, Yoann Madec, et al.
Journal of Medicinal Chemistry
|
April 29, 2025
Antibody-Drug Conjugates of NLRP3 Agonists: How Overcoming Lysosomal Accumulation Necessitated Noncanonical Linker Attachments
Paul S Riehl, Meng Yao Zhang, Payal Dhar, et al.
Nature Medicine
|
June 28, 2011
Low levels of SIV infection in sooty mangabey central memory CD⁴⁺ T cells are associated with limited CCR5 expression
Mirko Paiardini, Barbara Cervasi, Elane Reyes-Aviles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2015
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression
Daniel T Claiborne, Jessica L Prince, Eileen Scully, et al.
The Journal of Clinical Investigation
|
November 10, 2015
Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques
Luca Micci, Emily S Ryan, Rémi Fromentin, et al.
The Journal of Clinical Investigation
|
March 1, 2022
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
Justin Harper, Susan P Ribeiro, Chi Ngai Chan, et al.
Nature Medicine
|
April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
Justin Harper, Shari Gordon, Chi Ngai Chan, et al.
Nature Immunology
|
September 12, 2024
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
Susan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Research Square
|
April 1, 2025
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size
Khader Ghneim, Felipe Ten-Caten, Ana Carolina Santana, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 31) with videos related to
Sort By:
Page
of 4
Plos Pathogens
|
August 27, 2021
Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART
Maria Pino, Susan Pereira Ribeiro, Amélie Pagliuzza, et al.
Journal of the International AIDS Society
|
July 11, 2018
Systemic DPP4 activity is reduced during primary HIV-1 infection and is associated with intestinal RORC<sup>+</sup> CD4<sup>+</sup> cell levels: a surrogate marker candidate of HIV-induced intestinal damage
Mickaël J Ploquin, Armanda Casrouge, Yoann Madec, et al.
Journal of Medicinal Chemistry
|
April 29, 2025
Antibody-Drug Conjugates of NLRP3 Agonists: How Overcoming Lysosomal Accumulation Necessitated Noncanonical Linker Attachments
Paul S Riehl, Meng Yao Zhang, Payal Dhar, et al.
Nature Medicine
|
June 28, 2011
Low levels of SIV infection in sooty mangabey central memory CD⁴⁺ T cells are associated with limited CCR5 expression
Mirko Paiardini, Barbara Cervasi, Elane Reyes-Aviles, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 3, 2015
Replicative fitness of transmitted HIV-1 drives acute immune activation, proviral load in memory CD4+ T cells, and disease progression
Daniel T Claiborne, Jessica L Prince, Eileen Scully, et al.
The Journal of Clinical Investigation
|
November 10, 2015
Interleukin-21 combined with ART reduces inflammation and viral reservoir in SIV-infected macaques
Luca Micci, Emily S Ryan, Rémi Fromentin, et al.
The Journal of Clinical Investigation
|
March 1, 2022
Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
Justin Harper, Susan P Ribeiro, Chi Ngai Chan, et al.
Nature Medicine
|
April 15, 2020
CTLA-4 and PD-1 dual blockade induces SIV reactivation without control of rebound after antiretroviral therapy interruption
Justin Harper, Shari Gordon, Chi Ngai Chan, et al.
Nature Immunology
|
September 12, 2024
Dual blockade of IL-10 and PD-1 leads to control of SIV viral rebound following analytical treatment interruption
Susan Pereira Ribeiro, Zachary Strongin, Hugo Soudeyns, et al.
Research Square
|
April 1, 2025
TGF-β mediates epigenetic control of innate antiviral responses and SIV reservoir size
Khader Ghneim, Felipe Ten-Caten, Ana Carolina Santana, et al.
Page
of 4